Immunoglobulin G hypogammaglobulinemia was found in 44.7% of patients with acute exacerbations of COPD receiving triple ...

Aim The bacterial and atypical etiology of acute exacerbations of chronic obstructive pulmonary disease was investigated and the diagnostic techniques used were compared among 92 hospitalized ...

So a COPD exacerbation is a period where people with COPD will notice an acute deterioration in their symptoms. And these will probably last a few days, and they may experience shortness of breath ...

and larger studies with more even distribution between groups are needed in order to evaluate these differences and conclude whether the atypical pathogens are cause of exacerbation in COPD ...

Key findings• This study investigated the U-shaped nonlinear relationship between admission oxygen saturation (SpO2) and ...

Live webcasts for the events will also be accessible on Connect’s website in the Investors section under Presentations, Events & News at investors.connectbiopharm.com. An archived replay of the ...

According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...

China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease: London, UK Friday, February 21, 2025, 09:00 Hrs [IST] GSK plc announ ...

The digital Healthy at Home intervention appeared to improve quality of life for patients and decreased COPD-related distress ...

Amgen and AstraZeneca's Tezspire showed significant reductions in nasal polyp severity, congestion, and surgery need in CRSwNP patients in the Phase 3 WAYPOINT trial.